225 related articles for article (PubMed ID: 27666565)
1. Female cancer survivors exposed to alkylating-agent chemotherapy have unique reproductive hormone profiles.
Johnson L; Sammel MD; Schanne A; Lechtenberg L; Prewitt M; Gracia C
Fertil Steril; 2016 Dec; 106(7):1793-1799.e2. PubMed ID: 27666565
[TBL] [Abstract][Full Text] [Related]
2. Characterizing the reproductive hormone milieu in infertile women with diminished ovarian reserve.
Pal L; Zhang K; Zeitlian G; Santoro N
Fertil Steril; 2010 Mar; 93(4):1074-9. PubMed ID: 19100532
[TBL] [Abstract][Full Text] [Related]
3. Monitoring the menstrual cycle of humans and lowland gorillas based on urinary profiles of bioactive follicle-stimulating hormone and steroid metabolites.
Dahl KD; Czekala NM; Lim P; Hsueh AJ
J Clin Endocrinol Metab; 1987 Mar; 64(3):486-93. PubMed ID: 3102537
[TBL] [Abstract][Full Text] [Related]
4. The prediction and/or detection of ovulation by means of urinary steroid assays.
Cekan SZ; Beksac MS; Wang E; Shi S; Masironi B; Landgren BM; Diczfalusy E
Contraception; 1986 Apr; 33(4):327-45. PubMed ID: 3731775
[TBL] [Abstract][Full Text] [Related]
5. Monitoring the menstrual cycle: Comparison of urinary and serum reproductive hormones referenced to true ovulation.
Roos J; Johnson S; Weddell S; Godehardt E; Schiffner J; Freundl G; Gnoth C
Eur J Contracept Reprod Health Care; 2015; 20(6):438-50. PubMed ID: 26018113
[TBL] [Abstract][Full Text] [Related]
6. Urinary ovarian and gonadotropin hormone levels in premenopausal women with low bone mass.
Sowers M; Randolph JF; Crutchfield M; Jannausch ML; Shapiro B; Zhang B; La Pietra M
J Bone Miner Res; 1998 Jul; 13(7):1191-202. PubMed ID: 9661084
[TBL] [Abstract][Full Text] [Related]
7. Body size and ethnicity are associated with menstrual cycle alterations in women in the early menopausal transition: The Study of Women's Health across the Nation (SWAN) Daily Hormone Study.
Santoro N; Lasley B; McConnell D; Allsworth J; Crawford S; Gold EB; Finkelstein JS; Greendale GA; Kelsey J; Korenman S; Luborsky JL; Matthews K; Midgley R; Powell L; Sabatine J; Schocken M; Sowers MF; Weiss G
J Clin Endocrinol Metab; 2004 Jun; 89(6):2622-31. PubMed ID: 15181033
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of ovulation by low-dose mifepristone (RU 486).
Ledger WL; Sweeting VM; Hillier H; Baird DT
Hum Reprod; 1992 Aug; 7(7):945-50. PubMed ID: 1331167
[TBL] [Abstract][Full Text] [Related]
9. Characterization of reproductive hormonal dynamics in the perimenopause.
Santoro N; Brown JR; Adel T; Skurnick JH
J Clin Endocrinol Metab; 1996 Apr; 81(4):1495-501. PubMed ID: 8636357
[TBL] [Abstract][Full Text] [Related]
10. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
Croxatto HB; Salvatierra AM; Romero C; Spitz IM
J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
[TBL] [Abstract][Full Text] [Related]
11. Monitoring of ovarian activity by daily measurement of urinary excretion rates of oestrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part III: variability of normal menstrual cycle profiles.
Blackwell LF; Vigil P; Cooke DG; d'Arcangues C; Brown JB
Hum Reprod; 2013 Dec; 28(12):3306-15. PubMed ID: 24170744
[TBL] [Abstract][Full Text] [Related]
12. Relationships between the luteinizing hormone surge and other characteristics of the menstrual cycle in normally ovulating women.
Direito A; Bailly S; Mariani A; Ecochard R
Fertil Steril; 2013 Jan; 99(1):279-285.e3. PubMed ID: 22999798
[TBL] [Abstract][Full Text] [Related]
13. Monitoring of ovarian activity by measurement of urinary excretion rates of estrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part II: reliability of home testing.
Blackwell LF; Vigil P; Gross B; d'Arcangues C; Cooke DG; Brown JB
Hum Reprod; 2012 Feb; 27(2):550-7. PubMed ID: 22131389
[TBL] [Abstract][Full Text] [Related]
14. The concentrations of urinary oestrone-3-glucuronide, LH and pregnanediol-3alpha-glucuronide as indices of ovarian function.
Collins WP; Collins PO; Kilpatrick MJ; Manning PA; Pike JM; Tyler JP
Acta Endocrinol (Copenh); 1979 Feb; 90(2):336-48. PubMed ID: 419920
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of the urinary luteinizing hormone surge in young ovulatory women.
Park SJ; Goldsmith LT; Skurnick JH; Wojtczuk A; Weiss G
Fertil Steril; 2007 Sep; 88(3):684-90. PubMed ID: 17434509
[TBL] [Abstract][Full Text] [Related]
16. Relation of cardiovascular risk factors in women approaching menopause to menstrual cycle characteristics and reproductive hormones in the follicular and luteal phases.
Matthews KA; Santoro N; Lasley B; Chang Y; Crawford S; Pasternak RC; Sutton-Tyrrell K; Sowers M
J Clin Endocrinol Metab; 2006 May; 91(5):1789-95. PubMed ID: 16492698
[TBL] [Abstract][Full Text] [Related]
17. Partial recovery of luteal function after bariatric surgery in obese women.
Rochester D; Jain A; Polotsky AJ; Polotsky H; Gibbs K; Isaac B; Zeitlian G; Hickmon C; Feng S; Santoro N
Fertil Steril; 2009 Oct; 92(4):1410-1415. PubMed ID: 18829008
[TBL] [Abstract][Full Text] [Related]
18. Postpartum return of ovarian activity in nonbreastfeeding women monitored by urinary assays.
Gray RH; Campbell OM; Zacur HA; Labbok MH; MacRae SL
J Clin Endocrinol Metab; 1987 Apr; 64(4):645-50. PubMed ID: 3818896
[TBL] [Abstract][Full Text] [Related]
19. Ovarian reserve after treatment with alkylating agents during childhood.
Thomas-Teinturier C; Allodji RS; Svetlova E; Frey MA; Oberlin O; Millischer AE; Epelboin S; Decanter C; Pacquement H; Tabone MD; Sudour-Bonnange H; Baruchel A; Lahlou N; De Vathaire F
Hum Reprod; 2015 Jun; 30(6):1437-46. PubMed ID: 25801499
[TBL] [Abstract][Full Text] [Related]
20. Urinary follicle-stimulating hormone peak as a biomarker for estimating the day of ovulation.
Li H; Chen J; Overstreet JW; Nakajima ST; Lasley BL
Fertil Steril; 2002 May; 77(5):961-6. PubMed ID: 12009351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
